About Us > Company

First overseas laboratory officially launched and operated in Basel, Switzerland

Launched overseas brand "HYQURE"

Supported clients in achieving over 100 successful IND and BLA approvals, covering China, the US, Europe, Japan, South Korea, Australia and other regions

Completed Series B financing (led by CMB International and other investors)

Signed and delivered first overseas commercial project

Supported client in achieving first license-out transaction

Number of cooperative clients exceeded 300

South China Laboratory obtained CNAS accreditation

Established a joint venture with BeiGene BIC and set up South China Laboratory

Phase II Laboratory passed CNAS re-accreditation and scope expansion assessment

Passed EU QP on-site inspection and obtained GMP compliance statement

Signed first overseas project order

Completed Series A+ financing (co-led by Guofang Capital and Haibang Capital)

Completed construction of Shanghai R&D Center and Phase II Laboratory in Jiashan

Phase II Laboratory obtained BLS-2/BLS-2+ registration from Zhejiang Provincial Health Commission and Department of Agriculture

Laboratory accredited by China National Accreditation Service for Conformity Assessment (CNAS)

Became a one-stop service provider for VC, CLC and viral vector characterization compliant with China-US dual filings

Completed Series A financing (led by Chengsu Capital)

Certified with UKAS ISO 9001 Management System

Achieved first successful IND application

Delivered first successful China-US dual filing project

Company established and Phase I construction of Zhejiang Testing Center completed

Completed angel round financing (led by Jinpu Health Fund)

Obtained investment support from Yunfeng Healthcare Fund